Discuss This Drug

polidocanol

CHEBI:CHEBI_46859

Definition

A hydroxypolyether that is nonaethylene glycol in which one of the terminal hydroxy functions is substituted by a lauryl (dodecyl) group.

Chemical Information

Molecular Formula
C30H62O10
Molecular Mass
582.80728
Charge
0
SMILES
CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO
InChI
InChI=1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3
InChIKey
ONJQDTZCDSESIW-UHFFFAOYSA-N

Alternative Names

  • 3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol
  • DODECYL NONA ETHYLENE GLYCOL ETHER
  • Nonaethylene glycol monododecyl ether
  • nonaethylene glycol monolauryl ether
  • Polidocanol

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:46859
DRON_00010000
968170
oboInOwl#hasDbXref
Wikipedia:Polidocanol

Additional References

Wikipedia:Polidocanol

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:46859
rxcui
1485070
active_ingredient_strength
1 kg/kg
package_marketing_start_date
20160622
active_ingredient_name
POLIDOCANOL
manufacturer_name
Methapharm, Inc
spl_set_id
bb1f342b-5352-4059-a0b2-e60fd652fd28
package_description
1 POUCH in 1 CARTON (60635-118-01) / 1 KIT in 1 POUCH * 18 mL in 1 CANISTER (60635-018-01) * 303 mL in 1 CANISTER
unii
0AWH8BFG9A
nui
N0000009905
upc
0367850141056
pharm_class_epc
Sclerosing Agent [EPC]
pharm_class
Sclerosing Activity [MoA]
pharm_class_pe
Vascular Sclerosing Activity [PE]
pharm_class_moa
Sclerosing Activity [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_799
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect25151
owl#annotatedSource
t224767
owl#someValuesFrom
t3147425
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
968170
oboInOwl#hasDbXref
Wikipedia:Polidocanol
oboInOwl#hasAlternativeId
CHEBI:41445
oboInOwl#id
CHEBI:46859
generic_name
POLIDOCANOL
dosage_form
LIQUID
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
INTRAVENOUS
marketing_start_date
20131125
labeler_name
Methapharm, Inc
product_ndc
52919-021
spl_id
b812e177-5415-42dc-820e-d7b96add60a2
package_ndc
52919-021-14
brand_name
Asclera
brand_name_base
Asclera
application_number
NDA021201
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_38828
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_39784